NIOX Group (NIOX Group) Research & Development : $2.91 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is NIOX Group Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. NIOX Group's Research & Development for the six months ended in Dec. 2023 was $1.39 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $2.91 Mil.

NIOX Group Research & Development Historical Data

The historical data trend for NIOX Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NIOX Group Research & Development Chart

NIOX Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

66.97

9.14

6.12

3.90

2.91

NIOX Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Research & Development	Get a 7-Day Free Trial															2.66	2.34	1.58	1.52	1.39

NIOX Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $2.91 Mil.

NIOX Group (OTCPK:CSSPF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

NIOX Group Research & Development Related Terms

Thank you for viewing the detailed overview of NIOX Group's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

NIOX Group (NIOX Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NIOX Group PLC (OTCPK:CSSPF) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

NIOX:UK 82C:Germany

Address

Edmund Halley Road, Hayakawa Building, The Oxford Science Park, Oxford, GBR, OX4 4GB

Website

https://investors.niox.com

NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.